Recombinant Human Serum Albumin Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Recombinant Human Serum Albumin Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
The research report on ‘Recombinant Human Serum Albumin Market’ provides a workplan for stakeholders for the estimated timeframe of -. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins.
Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Serum Albumin study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Recombinant Human Serum Albumin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Human Serum Albumin Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Recombinant Human Serum Albumin companies in 2021 (%)
The global Recombinant Human Serum Albumin market was valued at 72 million in 2021 and is projected to reach US$ 114.1 million by 2028, at a CAGR of 6.9% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
OsrHSA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Human Serum Albumin include Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen and HiMedia, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Recombinant Human Serum Albumin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Recombinant Human Serum Albumin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Recombinant Human Serum Albumin Market Segment Percentages, by Type, 2021 (%)
OsrHSA
ScrHSA
Global Recombinant Human Serum Albumin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Recombinant Human Serum Albumin Market Segment Percentages, by Application, 2021 (%)
Cell Culture Media
Medical Supplements
Other
Global Recombinant Human Serum Albumin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Recombinant Human Serum Albumin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Serum Albumin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Human Serum Albumin revenues share in global market, 2021 (%)
Key companies Recombinant Human Serum Albumin sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Recombinant Human Serum Albumin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Recombinant Human Serum Albumin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Human Serum Albumin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Human Serum Albumin Overall Market Size
2.1 Global Recombinant Human Serum Albumin Market Size: 2021 VS 2028
2.2 Global Recombinant Human Serum Albumin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Human Serum Albumin Sales: 2017-2028
3 Company Landscape
3.1 Top Recombinant Human Serum Albumin Players in Global Market
3.2 Top Global Recombinant Human Serum Albumin Companies Ranked by Revenue
3.3 Global Recombinant Human Serum Albumin Revenue by Companies
3.4 Global Recombinant Human Serum Albumin Sales by Companies
3.5 Global Recombinant Human Serum Albumin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Human Serum Albumin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Human Serum Albumin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Human Serum Albumin Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Human Serum Albumin Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Human Serum Albumin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Human Serum Albumin Market Size Markets, 2021 & 2028
4.1.2 OsrHSA
4.1.3 ScrHSA
4.2 By Type - Global Recombinant Human Serum Albumin Revenue & Forecasts
4.2.1 By Type - Global Recombinant Human Serum Albumin Revenue, 2017-2022
4.2.2 By Type - Global Recombinant Human Serum Albumin Revenue, 2023-2028
4.2.3 By Type - Global Recombinant Human Serum Albumin Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant Human Serum Albumin Sales & Forecasts
4.3.1 By Type - Global Recombinant Human Serum Albumin Sales, 2017-2022
4.3.2 By Type - Global Recombinant Human Serum Albumin Sales, 2023-2028
4.3.3 By Type - Global Recombinant Human Serum Albumin Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant Human Serum Albumin Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Recombinant Human Serum Albumin Market Size, 2021 & 2028
5.1.2 Cell Culture Media
5.1.3 Medical Supplements
5.1.4 Other
5.2 By Application - Global Recombinant Human Serum Albumin Revenue & Forecasts
5.2.1 By Application - Global Recombinant Human Serum Albumin Revenue, 2017-2022
5.2.2 By Application - Global Recombinant Human Serum Albumin Revenue, 2023-2028
5.2.3 By Application - Global Recombinant Human Serum Albumin Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Human Serum Albumin Sales & Forecasts
5.3.1 By Application - Global Recombinant Human Serum Albumin Sales, 2017-2022
5.3.2 By Application - Global Recombinant Human Serum Albumin Sales, 2023-2028
5.3.3 By Application - Global Recombinant Human Serum Albumin Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Human Serum Albumin Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Recombinant Human Serum Albumin Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Human Serum Albumin Revenue & Forecasts
6.2.1 By Region - Global Recombinant Human Serum Albumin Revenue, 2017-2022
6.2.2 By Region - Global Recombinant Human Serum Albumin Revenue, 2023-2028
6.2.3 By Region - Global Recombinant Human Serum Albumin Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Human Serum Albumin Sales & Forecasts
6.3.1 By Region - Global Recombinant Human Serum Albumin Sales, 2017-2022
6.3.2 By Region - Global Recombinant Human Serum Albumin Sales, 2023-2028
6.3.3 By Region - Global Recombinant Human Serum Albumin Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Recombinant Human Serum Albumin Revenue, 2017-2028
6.4.2 By Country - North America Recombinant Human Serum Albumin Sales, 2017-2028
6.4.3 US Recombinant Human Serum Albumin Market Size, 2017-2028
6.4.4 Canada Recombinant Human Serum Albumin Market Size, 2017-2028
6.4.5 Mexico Recombinant Human Serum Albumin Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Recombinant Human Serum Albumin Revenue, 2017-2028
6.5.2 By Country - Europe Recombinant Human Serum Albumin Sales, 2017-2028
6.5.3 Germany Recombinant Human Serum Albumin Market Size, 2017-2028
6.5.4 France Recombinant Human Serum Albumin Market Size, 2017-2028
6.5.5 U.K. Recombinant Human Serum Albumin Market Size, 2017-2028
6.5.6 Italy Recombinant Human Serum Albumin Market Size, 2017-2028
6.5.7 Russia Recombinant Human Serum Albumin Market Size, 2017-2028
6.5.8 Nordic Countries Recombinant Human Serum Albumin Market Size, 2017-2028
6.5.9 Benelux Recombinant Human Serum Albumin Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Recombinant Human Serum Albumin Revenue, 2017-2028
6.6.2 By Region - Asia Recombinant Human Serum Albumin Sales, 2017-2028
6.6.3 China Recombinant Human Serum Albumin Market Size, 2017-2028
6.6.4 Japan Recombinant Human Serum Albumin Market Size, 2017-2028
6.6.5 South Korea Recombinant Human Serum Albumin Market Size, 2017-2028
6.6.6 Southeast Asia Recombinant Human Serum Albumin Market Size, 2017-2028
6.6.7 India Recombinant Human Serum Albumin Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Recombinant Human Serum Albumin Revenue, 2017-2028
6.7.2 By Country - South America Recombinant Human Serum Albumin Sales, 2017-2028
6.7.3 Brazil Recombinant Human Serum Albumin Market Size, 2017-2028
6.7.4 Argentina Recombinant Human Serum Albumin Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Human Serum Albumin Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Recombinant Human Serum Albumin Sales, 2017-2028
6.8.3 Turkey Recombinant Human Serum Albumin Market Size, 2017-2028
6.8.4 Israel Recombinant Human Serum Albumin Market Size, 2017-2028
6.8.5 Saudi Arabia Recombinant Human Serum Albumin Market Size, 2017-2028
6.8.6 UAE Recombinant Human Serum Albumin Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Albumedix
7.1.1 Albumedix Corporate Summary
7.1.2 Albumedix Business Overview
7.1.3 Albumedix Recombinant Human Serum Albumin Major Product Offerings
7.1.4 Albumedix Recombinant Human Serum Albumin Sales and Revenue in Global (2017-2022)
7.1.5 Albumedix Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Recombinant Human Serum Albumin Major Product Offerings
7.2.4 Merck Recombinant Human Serum Albumin Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Ventria (InVitria)
7.3.1 Ventria (InVitria) Corporate Summary
7.3.2 Ventria (InVitria) Business Overview
7.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Major Product Offerings
7.3.4 Ventria (InVitria) Recombinant Human Serum Albumin Sales and Revenue in Global (2017-2022)
7.3.5 Ventria (InVitria) Key News
7.4 NCPC
7.4.1 NCPC Corporate Summary
7.4.2 NCPC Business Overview
7.4.3 NCPC Recombinant Human Serum Albumin Major Product Offerings
7.4.4 NCPC Recombinant Human Serum Albumin Sales and Revenue in Global (2017-2022)
7.4.5 NCPC Key News
7.5 Oryzogen
7.5.1 Oryzogen Corporate Summary
7.5.2 Oryzogen Business Overview
7.5.3 Oryzogen Recombinant Human Serum Albumin Major Product Offerings
7.5.4 Oryzogen Recombinant Human Serum Albumin Sales and Revenue in Global (2017-2022)
7.5.5 Oryzogen Key News
7.6 HiMedia
7.6.1 HiMedia Corporate Summary
7.6.2 HiMedia Business Overview
7.6.3 HiMedia Recombinant Human Serum Albumin Major Product Offerings
7.6.4 HiMedia Recombinant Human Serum Albumin Sales and Revenue in Global (2017-2022)
7.6.5 HiMedia Key News
8 Global Recombinant Human Serum Albumin Production Capacity, Analysis
8.1 Global Recombinant Human Serum Albumin Production Capacity, 2017-2028
8.2 Recombinant Human Serum Albumin Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Human Serum Albumin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Human Serum Albumin Supply Chain Analysis
10.1 Recombinant Human Serum Albumin Industry Value Chain
10.2 Recombinant Human Serum Albumin Upstream Market
10.3 Recombinant Human Serum Albumin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Human Serum Albumin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Recombinant Human Serum Albumin Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|